Navigating the Impact of Chemotherapy Shortages on Cancer Care and Finances
Pharmaceutical, gynecologic oncology, and physician perspectives shed light on potentially mitigating the ongoing carboplatin and cisplatin shortages’ effects on cancer care in the United States.
Communication is ‘Paramount’ in Managing Chemotherapy Shortage
Recommendations penned by the American Society of Clinical Oncology and Society for Gynecologic Oncology may be critical in managing the ongoing chemotherapy shortage, according to Michael Ganio, PharmD, MS, BCPS, FASHP.
Expert Highlights Considerations for Imported Cisplatin Amid Drug Shortage
Chemotherapy agents imported from Chinese manufacturers may have barcodes that don’t work or be missing an NDC number, according to Michael Ganio, PharmD, MS, BCPS, FASHP.
Pharmacy Expert Details Causes of Carboplatin/Cisplatin Shortage in the U.S.
Results of a survey from the National Comprehensive Cancer Network indicate that almost all responding institutions are impacted by the carboplatin shortage.
2 Clarke Drive Cranbury, NJ 08512